人类葡萄糖类-1聚合动力学中的pH诱导开关
Karolina L Zapadka1, Frederik J Becher1, Shahid Uddin2
1Department of Chemistry, University of Cambridge , Cambridge CB2 1EW, U.K.
Journal of the American Chemical Society
|December 22, 2016
概括
人类葡萄糖类-1 (GLP-1) 聚合动力学显示了pH依赖的开关. 这项研究揭示了与N端质子相关的7. 5pH的异常度依赖的延迟时间,影响了制药应用.
科学领域:
- 生物化学
- 生物物理
- 制药科学
背景情况:
- 蛋白质和聚,包括粉样纤维的形成,在生物技术,制药和疾病方面具有重要意义.
- 人类葡萄糖类-1 (GLP-1) 是血糖调节的关键激素,其类似物广泛用于2型糖尿病治疗.
研究的目的:
- 阐明人类葡萄糖类-1 (GLP-1) 的聚合和粉样纤维化机制.
- 研究GLP-1聚合动力学中的pH诱导切换,并确定底层的分子决定因素.
主要方法:
- 通过在不同度和pH (7.5-8.2) 上使用硫黄素T光来监测GLP-1的粉状纤维的形成.
- 使用生物物理技术来描述聚合启动,纤维结构和稳定性.
- 估计可电离组的pKa值,以确定pH敏感的残留物.
主要成果:
- 在GLP-1聚合动力学中观察到明显的pH诱导的切换.
- 在pH8.2时,动力学与核化聚合模型保持一致.
- 在pH 7. 5下,异常的动力学显示出度延迟时间的增加,这归因于异路物种和缓慢的单体转化步骤.
结论:
- 在GLP-1聚合中,N端质子化/脱质子化被确定为pH诱导的切换的原因.
- 在促进GLP-1寡合化的条件下,偏离路径的物种形成是有利的.
- 了解这些聚合机制对于安全有效的GLP-1类药物使用至关重要.
相关概念视频
Glucagon-like Receptor Agonists
1.1K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K
GPCR Desensitization
8.5K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.5K


